Antimicrobial Agents and Chemotherapy, March 2004, p. 992-1003, Vol. 48, No. 3
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.3.992-1003.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Molecular Mechanisms of Tenofovir Resistance Conferred by Human Immunodeficiency Virus Type 1 Reverse Transcriptase Containing a Diserine Insertion after Residue 69 and Multiple Thymidine Analog-Associated Mutations
Kirsten L. White,1* James M. Chen,1 Nicolas A. Margot,1 Terri Wrin,2 Christos J. Petropoulos,2 Lisa K. Naeger,1 S. Swaminathan,1 and Michael D. Miller1
Gilead Sciences, Foster City, California, 94404,1
ViroLogic, Inc., South San Francisco, California, 940802
Received 29 May 2003/
Returned for modification 7 August 2003/
Accepted 13 November 2003
Two amino acids inserted between residues 69 and 70 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) are rare mutations that may develop in viruses containing multiple thymidine analog (zidovudine [AZT], stavudine)-associated mutations and that confer high-level resistance to all currently approved chain-terminating nucleoside and nucleotide RT inhibitors (NRTIs). The two known mechanisms of resistance to NRTIs are decreased incorporation and increased excision. The mechanism used by RT insertion mutants has not been described for tenofovir (TFV), a recently approved agent in this class. A patient-derived HIV-1 strain (strain FS-SSS) that contained an insertion mutation in a background of additional resistance mutations M41L, L74V, L210W, and T215Y was obtained. A second virus (strain FS) was derived from FS-SSS. In strain FS the insertion and T69S were reverted but the other resistance mutations were retained. The FS virus showed strong resistance to AZT but low-level changes in susceptibilities to other NRTIs and TFV. The FS-SSS virus showed reduced susceptibilities to all NRTIs including TFV. Steady-state kinetics demonstrated that the relative binding or incorporation of TFV was slightly decreased for FS-SSS RT compared to those for wild-type RT. However, significant ATP-mediated excision of TFV was detected for both mutant RT enzymes and followed the order FS-SSS RT > FS RT > wild-type RT. The presence of physiological concentrations of the +1 nucleotide inhibited TFV excision by the wild-type RT and slightly inhibited excision by the FS RT, whereas the level of excision by the FS-SSS RT remained high. Computer modeling suggests that the increased mobility of the ß3-ß4 loop may contribute to the high-level and broad NRTI resistance caused by the T69 insertion mutation.
* Corresponding author. Mailing address: Gilead Sciences, 333 Lakeside Dr., Foster City, CA 94404. Phone: (650) 522-5162. Fax: (650) 522-5890. E-mail: kwhite{at}gilead.com.
Antimicrobial Agents and Chemotherapy, March 2004, p. 992-1003, Vol. 48, No. 3
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.3.992-1003.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Marchand, B., White, K. L., Ly, J. K., Margot, N. A., Wang, R., McDermott, M., Miller, M. D., Gotte, M.
(2007). Effects of the Translocation Status of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on the Efficiency of Excision of Tenofovir. Antimicrob. Agents Chemother.
51: 2911-2919
[Abstract]
[Full Text]
-
Margot, N. A., Waters, J. M., Miller, M. D.
(2006). In Vitro Human Immunodeficiency Virus Type 1 Resistance Selections with Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine. Antimicrob. Agents Chemother.
50: 4087-4095
[Abstract]
[Full Text]
-
Winters, M. A., Merigan, T. C.
(2005). Insertions in the Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Genes: Clinical Impact and Molecular Mechanisms. Antimicrob. Agents Chemother.
49: 2575-2582
[Full Text]
-
Boyer, P. L., Imamichi, T., Sarafianos, S. G., Arnold, E., Hughes, S. H.
(2004). Effects of the {Delta}67 Complex of Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase on Nucleoside Analog Excision. J. Virol.
78: 9987-9997
[Abstract]
[Full Text]
-
Wang, L. Z., Kenyon, G. L., Johnson, K. A.
(2004). Novel Mechanism of Inhibition of HIV-1 Reverse Transcriptase by a New Non-nucleoside Analog, KM-1. J. Biol. Chem.
279: 38424-38432
[Abstract]
[Full Text]
-
Matamoros, T., Franco, S., Vazquez-Alvarez, B. M., Mas, A., Martinez, M. A., Menendez-Arias, L.
(2004). Molecular Determinants of Multi-nucleoside Analogue Resistance in HIV-1 Reverse Transcriptases Containing a Dipeptide Insertion in the Fingers Subdomain: EFFECT OF MUTATIONS D67N AND T215Y ON REMOVAL OF THYMIDINE NUCLEOTIDE ANALOGUES FROM BLOCKED DNA PRIMERS. J. Biol. Chem.
279: 24569-24577
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.